Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
Science Signaling|November 30, 2021
Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1April Lo, Kristin Holmes, Shriya Kamlapurkar, et al.
Molecular & Cellular Proteomics : MCP|May 9, 2015
Deep, Quantitative Coverage of the Lysine Acetylome Using Novel Anti-acetyl-lysine Antibodies and an Optimized Proteomic WorkflowTanya Svinkina, Hongbo Gu, Jeffrey C Silva, et al.
Iscience|June 30, 2021
PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPαEvelyn Ramberger, Valeria Sapozhnikova, Elisabeth Kowenz-Leutz, et al.
Nature Communications|June 21, 2020
Deconstructing sarcomeric structure-function relations in titin-BioID knock-in miceFranziska Rudolph, Claudia Fink, Judith Hüttemeister, et al.
Journal of Clinical Medicine|November 27, 2025
Early Detection of Acute Kidney Injury After Congenital Heart Surgery-Using Urine Proteomics to Identify New Biomarker Candidates: A Prospective Clinical StudyRaphael Seiler, Alexa Leona Herre, Marieluise Kirchner, et al.
Nature Communications|January 19, 2020
Rapid and deep-scale ubiquitylation profiling for biology and translational researchNamrata D Udeshi, Deepak C Mani, Shankha Satpathy, et al.
Cell Reports|November 9, 2022
Pan-claudin family interactome analysis reveals shared and specific interactionsLorena Suarez-Artiles, Tilman Breiderhoff, Rossana Girardello, et al.
Neoplasia (New York, N.Y.)|November 19, 2020
Patient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicineMaria Rivera, Iduna Fichtner, Annika Wulf-Goldenberg, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 16, 2020
The VGF-derived Peptide TLQP21 Impairs Purinergic Control of Chemotaxis and Phagocytosis in Mouse MicrogliaNirmeen Elmadany, Felipe de Almeida Sassi, Stefan Wendt, et al.
Oncogene|July 11, 2021
The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasisDennis Kobelt, Daniel Perez-Hernandez, Claudia Fleuter, et al.
Pageof 16